These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 15384479)
21. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk. Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635 [TBL] [Abstract][Full Text] [Related]
22. Screening for familial hypercholesterolemia: what is the most effective strategy? Daniels SR Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):130-1. PubMed ID: 18059381 [No Abstract] [Full Text] [Related]
25. Is lipoprotein (a)-apheresis useful? Bambauer R Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926 [TBL] [Abstract][Full Text] [Related]
26. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia. Miltiadous G; Saougos V; Cariolou M; Elisaf MS Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279 [TBL] [Abstract][Full Text] [Related]
27. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results. Bourbon M; Rato Q; Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457 [TBL] [Abstract][Full Text] [Related]
32. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease. Zambon A; Brown BG; Deeb SS; Brunzell JD J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853 [TBL] [Abstract][Full Text] [Related]
33. Beta-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia. Calandra S; Bertolini S; Pes GM; Deiana L; Tarugi P; Pisciotta L; Li Volti S; Li Volti G; Maccarone C Semin Vasc Med; 2004 Aug; 4(3):271-8. PubMed ID: 15630628 [TBL] [Abstract][Full Text] [Related]
34. The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. Gidding SS; Champagne MA; de Ferranti SD; Defesche J; Ito MK; Knowles JW; McCrindle B; Raal F; Rader D; Santos RD; Lopes-Virella M; Watts GF; Wierzbicki AS; Circulation; 2015 Dec; 132(22):2167-92. PubMed ID: 26510694 [No Abstract] [Full Text] [Related]
35. Haplotype of the angiotensinogen gene is associated with coronary heart disease in familial hypercholesterolemia. van der Net JB; Isaacs A; Dallinga-Thie GM; Kastelein JJ; Defesche JC; Steyerberg EW; Sijbrands EJ J Hypertens; 2008 Mar; 26(3):462-7. PubMed ID: 18300856 [TBL] [Abstract][Full Text] [Related]
36. Hypobetalipoproteinaemia secondary to chronic hepatitis C virus infection in a patient with familial hypercholesterolaemia. Bima AI; Hooper AJ; van Bockxmeer FM; Burnett JR Ann Clin Biochem; 2009 Sep; 46(Pt 5):420-2. PubMed ID: 19487412 [TBL] [Abstract][Full Text] [Related]
37. Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop. Bild DE; Williams RR; Brewer HB; Herd JA; Pearson TA; Stein E Am J Cardiol; 1993 Sep; 72(10):1D-5D. PubMed ID: 8105671 [TBL] [Abstract][Full Text] [Related]
38. [Familial hypercholesterolemia in St. Petersburg: diversity of mutations argues against a strong founder effect]. Zakharova FM; Tatishcheva IuA; Golubkov VI; Lipovetskiĭ BM; Konstantinov VO; Denisenko AD; Faergeman O; Vasil'ev VB; Mandel'shtam MIu Genetika; 2007 Sep; 43(9):1255-62. PubMed ID: 17990524 [TBL] [Abstract][Full Text] [Related]